These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 30396425)

  • 1. Use of camel single-domain antibodies for the diagnosis and treatment of zoonotic diseases.
    Lafaye P; Li T
    Comp Immunol Microbiol Infect Dis; 2018 Oct; 60():17-22. PubMed ID: 30396425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanobodies: natural single-domain antibodies.
    Muyldermans S
    Annu Rev Biochem; 2013; 82():775-97. PubMed ID: 23495938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of Nanobodies.
    Muyldermans S
    Annu Rev Anim Biosci; 2021 Feb; 9():401-421. PubMed ID: 33233943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A guide to: generation and design of nanobodies.
    Muyldermans S
    FEBS J; 2021 Apr; 288(7):2084-2102. PubMed ID: 32780549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting Nanobodies' Singular Traits.
    Ingram JR; Schmidt FI; Ploegh HL
    Annu Rev Immunol; 2018 Apr; 36():695-715. PubMed ID: 29490163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of nanobodies for therapeutic applications.
    Van Bockstaele F; Holz JB; Revets H
    Curr Opin Investig Drugs; 2009 Nov; 10(11):1212-24. PubMed ID: 19876789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Llama VHH antibody fragments against GFAP: better diffusion in fixed tissues than classical monoclonal antibodies.
    Perruchini C; Pecorari F; Bourgeois JP; Duyckaerts C; Rougeon F; Lafaye P
    Acta Neuropathol; 2009 Nov; 118(5):685-95. PubMed ID: 19597828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives for the Development of CD38-Specific Heavy Chain Antibodies as Therapeutics for Multiple Myeloma.
    Bannas P; Koch-Nolte F
    Front Immunol; 2018; 9():2559. PubMed ID: 30459772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction to heavy chain antibodies and derived Nanobodies.
    Vincke C; Muyldermans S
    Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of camelid heavy-chain variable domains (VHHs) in prevention and treatment of bacterial and viral infections.
    Wilken L; McPherson A
    Int Rev Immunol; 2018 Jan; 37(1):69-76. PubMed ID: 29182399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and Characterization of Single-Domain Antibodies from Immune Phage Display Libraries.
    Rossotti MA; Trempe F; van Faassen H; Hussack G; Arbabi-Ghahroudi M
    Methods Mol Biol; 2023; 2702():107-147. PubMed ID: 37679618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single domain antibodies from camelids in the treatment of microbial infections.
    De Greve H; Fioravanti A
    Front Immunol; 2024; 15():1334829. PubMed ID: 38827746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteric pharmacokinetics of monomeric and multimeric camelid nanobody single-domain antibodies.
    Debatis M; Danz H; Tremblay JM; Gaspie K; Kudej RK; Vigdorovich V; Sather N; Jaskiewicz JJ; Tzipori S; Shoemaker CB
    PLoS One; 2023; 18(11):e0291937. PubMed ID: 38011121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of camel single domain antibodies against Yersinia pestis V270 antigen based on a semi-synthetic single domain antibody library and development of a VHH-based lateral flow assay.
    Wang B; Wang C; Li B; Yang J; Lin P; Jin X; Niu Y; Zhang W; Zhang X; Huang Y
    Vet Med Sci; 2024 Jul; 10(4):e1532. PubMed ID: 38952277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable fragments of heavy chain antibodies (VHHs): a new magic bullet molecule of medicine?
    Smolarek D; Bertrand O; Czerwinski M
    Postepy Hig Med Dosw (Online); 2012 Jun; 66():348-58. PubMed ID: 22706121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1.
    Liu L; Wang W; Matz J; Ye C; Bracq L; Delon J; Kimata JT; Chen Z; Benichou S; Zhou P
    J Virol; 2016 Dec; 90(23):10642-10659. PubMed ID: 27654286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of Clostridium difficile toxin B with VHH-Fc fusions targeting the delivery and CROPs domains.
    Hussack G; Ryan S; van Faassen H; Rossotti M; MacKenzie CR; Tanha J
    PLoS One; 2018; 13(12):e0208978. PubMed ID: 30540857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of Clostridium difficile toxin-specific single-domain antibodies.
    Hussack G; Arbabi-Ghahroudi M; Mackenzie CR; Tanha J
    Methods Mol Biol; 2012; 911():211-39. PubMed ID: 22886255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanobodies derived from Camelids represent versatile biomolecules for biomedical applications.
    Yu X; Xu Q; Wu Y; Jiang H; Wei W; Zulipikaer A; Guo Y; Jirimutu ; Chen J
    Biomater Sci; 2020 Jul; 8(13):3559-3573. PubMed ID: 32490444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo neutralization of α-cobratoxin with high-affinity llama single-domain antibodies (VHHs) and a VHH-Fc antibody.
    Richard G; Meyers AJ; McLean MD; Arbabi-Ghahroudi M; MacKenzie R; Hall JC
    PLoS One; 2013; 8(7):e69495. PubMed ID: 23894495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.